DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Injectable Drug Delivery Market - Forecast to 2021" report to their offering.
The global injectable drug delivery market is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period.
The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors. However, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.
The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions.
Injectable drug delivery market by distribution channel is further segmented into hospitals and pharma stores. Hospitals are expected to account for a large share in this market, as hospitals provide injectables for the inpatients as well as to the outpatients, owing to which there is maximum sale of injectable formulations and devices through the hospitals. In addition, it provides pharmacy care for inpatients as well as patients from other clinics, ambulatory centers, patients discharged from healthcare facilities, and those receiving home care.
Companies Mentioned:
- Baxter International, Inc.
- Becton, Dickinson and Company
- ELI Lilly and Company
- Gerresheimer AG
- Pfizer, Inc.
- Sandoz (A Division of Novartis AG)
- Schott AG
- Terumo Corporation
-
Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Injectable Drug Delivery Market, By Type
8 Injectable Drug Delivery Market, By Formulation Packaging
9 Injectable Drug Delivery Market, By Therapeutic Application
10 Injectable Drug Delivery Market, By Usage Pattern
11 Injectable Drug Delivery Market, By Site of Administration
12 Injectable Drug Delivery Market, By Distribution Channel
13 Injectable Drug Delivery Market, By Facility of Use
14 Injectable Drug Delivery Market, By Region
15 Competitive Landscape
16 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/wwgnpl/injectable_drug
